M.V.I.

Role

Indications

Reactions

Secondary

Product Used For Unknown Indication	27.3%
Urinary Incontinence	18.2%
Arthralgia	9.1%
Arthritis	9.1%
Catheterisation Cardiac	9.1%
Heart Rate Irregular	9.1%
Osteoporosis	9.1%
Speech Disorder	9.1%

Concomitant

Drug Use For Unknown Indication	41.7%
Product Used For Unknown Indication	34.6%
Rheumatoid Arthritis	2.3%
Hypertension	2.3%
Blood Cholesterol Increased	2.0%
Crohn's Disease	1.8%
Pain	1.7%
Atrial Fibrillation	1.6%
High Density Lipoprotein Decreased	1.5%
Prophylaxis	1.4%
Blood Triglycerides Increased	1.2%
Multiple Myeloma	1.2%
Low Density Lipoprotein Increased	1.1%
Vitamin Supplementation	0.9%
Depression	0.9%
Gastrooesophageal Reflux Disease	0.8%
Supplementation Therapy	0.8%
Blood Pressure	0.7%
Diabetes Mellitus	0.7%
Non-small Cell Lung Cancer	0.7%

Flushing	25.4%
Pruritus	11.7%
Vomiting	7.2%
Paraesthesia	6.9%
Nausea	5.1%
Skin Burning Sensation	4.4%
Weight Decreased	3.8%
Diarrhoea	3.6%
Rash	3.5%
Blood Glucose Increased	2.9%
Drug Ineffective	2.9%
Urinary Tract Infection	2.8%
Death	2.7%
Headache	2.7%
Pyrexia	2.6%
Fatigue	2.5%
Tremor	2.5%
Pneumonia	2.4%
White Blood Cell Count Decreased	2.3%
Pain	2.1%

Interacting

Atrial Fibrillation	100.0%

Pneumonia	100.0%